CLUL1
gene geneOn this page
Summary
CLUL1 (clusterin like 1, HGNC:2096) is a protein-coding gene on chromosome 18p11.32, encoding Clusterin-like protein 1 (Q15846).
Predicted to enable misfolded protein binding activity. Predicted to be located in extracellular region. Predicted to be active in extracellular space and nucleus.
Source: NCBI Gene 27098 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 75 total — 1 pathogenic
- MANE Select transcript:
NM_001393344
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2096 |
| Approved symbol | CLUL1 |
| Name | clusterin like 1 |
| Location | 18p11.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000079101 |
| Ensembl biotype | protein_coding |
| OMIM | 616990 |
| Entrez | 27098 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 8 protein_coding, 4 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000338387, ENST00000400606, ENST00000540035, ENST00000579443, ENST00000579494, ENST00000579912, ENST00000580436, ENST00000581619, ENST00000582020, ENST00000584046, ENST00000584370, ENST00000585155, ENST00000692774
RefSeq mRNA: 10 — MANE Select: NM_001393344
NM_001289036, NM_001318522, NM_001375492, NM_001393344, NM_001393345, NM_001393346, NM_001393347, NM_001393348, NM_014410, NM_199167
CCDS: CCDS42405
Canonical transcript exons
ENST00000692774 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001208384 | 641327 | 641541 |
| ENSE00001230733 | 644910 | 645097 |
| ENSE00001230744 | 633298 | 633435 |
| ENSE00001230752 | 627097 | 627529 |
| ENSE00002698264 | 649898 | 650182 |
| ENSE00002700165 | 596988 | 597129 |
| ENSE00003471021 | 606978 | 607099 |
| ENSE00003486455 | 617988 | 618106 |
| ENSE00003529187 | 619213 | 619361 |
| ENSE00003661277 | 624865 | 625032 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 84.70.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5143 / max 86.3404, expressed in 189 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 169053 | 0.3873 | 183 |
| 169055 | 0.0834 | 7 |
| 169056 | 0.0309 | 4 |
| 169054 | 0.0127 | 4 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pigmented layer of retina | UBERON:0001782 | 84.70 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.02 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 79.89 | gold quality |
| buccal mucosa cell | CL:0002336 | 78.46 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.41 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.13 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.80 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 72.80 | gold quality |
| thyroid gland | UBERON:0002046 | 71.95 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 71.72 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 71.43 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.17 | gold quality |
| pituitary gland | UBERON:0000007 | 70.53 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.43 | gold quality |
| right frontal lobe | UBERON:0002810 | 70.29 | gold quality |
| secondary oocyte | CL:0000655 | 70.11 | silver quality |
| cortical plate | UBERON:0005343 | 69.88 | gold quality |
| prostate gland | UBERON:0002367 | 69.78 | gold quality |
| frontal cortex | UBERON:0001870 | 69.24 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 69.14 | gold quality |
| cingulate cortex | UBERON:0003027 | 69.06 | gold quality |
| cerebellar cortex | UBERON:0002129 | 69.03 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 68.95 | gold quality |
| hypothalamus | UBERON:0001898 | 68.94 | gold quality |
| neocortex | UBERON:0001950 | 68.86 | gold quality |
| spinal cord | UBERON:0002240 | 68.41 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.01 | gold quality |
| cerebral cortex | UBERON:0000956 | 67.48 | gold quality |
| cerebellum | UBERON:0002037 | 67.47 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 1702.99 |
| E-GEOD-98556 | yes | 1601.27 |
| E-MTAB-8060 | no | 104.73 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MYC
miRNA regulators (miRDB)
34 targeting CLUL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-2053 | 99.57 | 69.15 | 1635 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-501-5P | 98.77 | 68.88 | 1328 |
| HSA-MIR-4272 | 98.76 | 68.74 | 1810 |
| HSA-MIR-496 | 98.66 | 69.80 | 931 |
| HSA-MIR-4511 | 98.32 | 67.97 | 1500 |
| HSA-MIR-138-1-3P | 98.25 | 67.89 | 867 |
| HSA-MIR-1243 | 97.07 | 65.44 | 719 |
| HSA-MIR-3674 | 97.01 | 68.86 | 1171 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | clul1 | ENSDARG00000055595 |
| rattus_norvegicus | Clul1 | ENSRNOG00000059237 |
Paralogs (1): CLU (ENSG00000120885)
Protein
Protein identifiers
Clusterin-like protein 1 — Q15846 (reviewed: Q15846)
Alternative names: Retinal-specific clusterin-like protein
All UniProt accessions (5): Q15846, F5GWQ8, J3QKW8, R4GN76, R4GN95
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the clusterin family.
RefSeq proteins (10): NP_001275965, NP_001305451, NP_001362421, NP_001380273, NP_001380274, NP_001380275, NP_001380276, NP_001380277, NP_055225, NP_954636 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000753 | Clusterin-like | Family |
| IPR016014 | Clusterin_N | Domain |
| IPR016015 | Clusterin_C | Domain |
Pfam: PF01093
UniProt features (14 total): glycosylation site 6, disulfide bond 5, signal peptide 1, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15846-F1 | 65.03 | 0.15 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (5): 116–325, 119–322, 124–315, 131–305, 105–333
Glycosylation sites (6): 196, 257, 311, 351, 412, 431
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
RIZKI_TUMOR_INVASIVENESS_3D_DN, MODULE_113, DANG_BOUND_BY_MYC, GOMF_MISFOLDED_PROTEIN_BINDING, KRAS.300_UP.V1_UP, KRAS.600_UP.V1_UP, HMGA1_TARGET_GENES, MAFG_TARGET_GENES, SRSF9_TARGET_GENES, THRA_TARGET_GENES, TOP2B_TARGET_GENES, ZNF664_TARGET_GENES, ZNF8_TARGET_GENES, MIR7856_5P, MIR2053
GO Biological Process (0):
GO Molecular Function (1): misfolded protein binding (GO:0051787)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), nucleus (GO:0005634), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
807 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLUL1 | ENOSF1 | Q7L5Y1 | 621 |
| CLUL1 | AKAIN1 | P0CW23 | 609 |
| CLUL1 | CETN1 | Q12798 | 540 |
| CLUL1 | MYOM1 | P52179 | 518 |
| CLUL1 | COLEC12 | Q5KU26 | 509 |
| CLUL1 | THOC1 | Q96FV9 | 507 |
| CLUL1 | LPIN2 | Q92539 | 505 |
| CLUL1 | ZBTB14 | O43829 | 477 |
| CLUL1 | EMILIN2 | Q9BXX0 | 447 |
| CLUL1 | RBP3 | P10745 | 423 |
| CLUL1 | MYL12A | P19105 | 419 |
| CLUL1 | MYL12B | O14950 | 407 |
| CLUL1 | SMCHD1 | A6NHR9 | 400 |
| CLUL1 | ADCYAP1 | P18509 | 400 |
| CLUL1 | DLGAP1 | P78335 | 398 |
IntAct
1 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LECT2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): CLUL1 (Affinity Capture-MS), EEA1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1B0GVN3, A0JPP4, A4H257, A4H258, A4H260, A6NKB5, A6QLI2, A7WNB0, B9EKR1, F5HB98, O75969, O77797, P11450, P15522, P33735, P33736, P47867, P61110, P80195, P81447, Q00997, Q15846, Q1XI86, Q2LCV6, Q30KK0, Q32KL7, Q32MG2, Q3ZRW6, Q3ZRW7, Q49AJ0, Q569E4, Q5RBQ2, Q5RII3, Q5XI62, Q641I1, Q6AXV6, Q6UW49, Q8JSZ3, Q8TAL5, Q95KN1
Diamond homologs: P05371, P10909, P14018, P14683, P17697, P25473, Q06890, Q15846, Q29482, Q29549, Q3ZRW6, Q3ZRW7, Q3ZRW9, Q9XSC5, Q95KN1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
75 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 62 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3062373 | GRCh37/hg19 18p11.32-11.21(chr18:136227-15157836)x3 | Pathogenic |
SpliceAI
2057 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:618102:GAAGA:G | donor_gain | 1.0000 |
| 18:618105:GA:G | donor_gain | 1.0000 |
| 18:618107:G:GG | donor_gain | 1.0000 |
| 18:619357:AGCAG:A | donor_loss | 1.0000 |
| 18:619358:GCAG:G | donor_gain | 1.0000 |
| 18:619359:CAGGT:C | donor_loss | 1.0000 |
| 18:619360:AGGTA:A | donor_loss | 1.0000 |
| 18:619361:GG:G | donor_loss | 1.0000 |
| 18:619363:T:A | donor_loss | 1.0000 |
| 18:625029:TAAGG:T | donor_loss | 1.0000 |
| 18:625031:AGGT:A | donor_loss | 1.0000 |
| 18:633296:A:AG | acceptor_gain | 1.0000 |
| 18:633297:G:GA | acceptor_gain | 1.0000 |
| 18:644909:GGTA:G | acceptor_gain | 1.0000 |
| 18:597127:CAGG:C | donor_loss | 0.9900 |
| 18:597131:T:G | donor_loss | 0.9900 |
| 18:614560:GC:G | donor_gain | 0.9900 |
| 18:617986:A:AG | acceptor_gain | 0.9900 |
| 18:617987:G:GA | acceptor_gain | 0.9900 |
| 18:618091:A:AG | donor_gain | 0.9900 |
| 18:618092:G:GG | donor_gain | 0.9900 |
| 18:618104:AGA:A | donor_gain | 0.9900 |
| 18:618105:GAG:G | donor_gain | 0.9900 |
| 18:619208:TTTA:T | acceptor_loss | 0.9900 |
| 18:619211:A:AG | acceptor_gain | 0.9900 |
| 18:619211:AGGT:A | acceptor_loss | 0.9900 |
| 18:619212:G:GC | acceptor_loss | 0.9900 |
| 18:619212:G:GG | acceptor_gain | 0.9900 |
| 18:619212:G:T | acceptor_gain | 0.9900 |
| 18:619359:C:T | donor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000025117 (18:621793 G>A), RS1000039245 (18:646474 C>G), RS1000040792 (18:642361 G>A), RS1000107593 (18:648132 A>C), RS1000200696 (18:615615 A>G), RS1000217760 (18:639917 G>C), RS1000312968 (18:639750 G>A), RS1000340102 (18:609696 T>C), RS1000445197 (18:644173 C>G,T), RS1000495655 (18:646040 A>G), RS1000553394 (18:641261 C>T), RS1000570484 (18:597177 C>A), RS1000594145 (18:599727 T>C), RS1000613219 (18:615327 G>T), RS1000616921 (18:638067 G>C)
Disease associations
OMIM: gene MIM:616990 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002709_3 | Electroencephalogram traits | 6.000000e-06 |
| GCST004635_37 | Testicular germ cell tumor | 4.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004357 | electroencephalogram measurement |
| EFO:0006870 | alpha wave measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 4 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| perfluorooctane sulfonic acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| entinostat | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Lead | affects expression | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Cyclosporine | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): testicular germ cell tumor